SCHEMBL18922294

SCHEMBL18922294

CCOCC[C@](C)(C[C@H](N)Cc1ccc(-c2cc(Cl)ccc2F)cc1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.44
▸ ACE P12821 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20681857 1.00 MME (0.44) MMEACE
SCHEMBL21351243 0.91 MME (0.45) MMEACE
SCHEMBL19788067 0.91 MME (0.45) MMEACE
SCHEMBL19331567 0.90 MME (0.46) MMEACE
SCHEMBL19331564 0.90 MME (0.46) MMEACE
SCHEMBL15472737 0.90 MME (0.46) MMEACE
Hydrochloric Acid SCHEMBL19376905 0.90 MME (0.45) MMEACE
SCHEMBL19788074 0.88 MME (0.45) MMEACE
SCHEMBL19687852 0.88 MME (0.45) MMEACE
SCHEMBL19687938 0.88 MME (0.41) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9670186-B2 Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (US) 2017-06-06 — — US disclosed
Send feedback